Advancements to Perform Sequencing in Less Time is expected to driving Targeted DNA/RNA Sequencing Market Toward Rapid Growth

The global Targeted DNA/RNA Sequencing Market is expected to reach USD 15.9 billion by 2025, according to a new report by Grand View Research, Inc. Targeted Sequencing has emerged as a key technology in life science research by enabling examination of specific region of interest while keeping the seq. cost as well as complexity of data under manageable limits.

germany-targeted-dna-rna-sequencing-market.png

This approach enhances sequencing depth by allowing evaluation of specific coding regions within genes or specific genes, which are known to harbor mutations for disease pathogenesis. Several research projects have employed this technology to avoid wastage of information and extra cost and study only relevant genes. Number of such projects continue to grow, consequently driving the market.

Innovations to address the pitfalls of targeted enrichment method are anticipated to enhance the usage rate of this technology throughout the forecast period. Moreover, with decrease in seq-cost and improvement in informatics, targeted methods have become more accessible for use in clinical settings than ever.

Access Full Research on Targeted DNA/RNA Sequencing Market: http://www.grandviewresearch.com/industry-analysis/targeted-dna-rna-sequencing-market

 Further key findings from the report suggest:

  • Next-Generation Sequencing (NGS) technology captured a major share in 2016
  • Rapid advancements in NGS and its ancillary protocols can be attributed to the growth of this segment
  • Out of all the NGS-based targeted methods, exome-seq held the largest share
  • This can be attributed to the fact that though it accounts for less than 2% of the genome, it contains 85% of the known disease-relevant variants
  • Entire targeted approach is broken down into presequencing, sequence determination, and data analysis
  • Being the most crucial step, sequencing accounted for the largest share
  • This space has revolutionized various applications of life sciences, including human biomedical research, plant & animal sciences, drug discovery, and others
  • Out of all, human biomedical research is estimated to be the largest application of this space due its high usage in studying disease pathogenesis
  • The market is bifurcated into DNA-seq and RNA-seq, based on the sample type
  • DNA-sequencing has been estimated to generate the higher revenue over its counterpart segment. This can be attributed to the presence of wide range of products and kits for DNA-seq
  • As per end use, academic research is estimated to be the largest segment owing to the increase in seq-based projects at universities and other academic centers
  • North America held the largest share owing to the presence of effective regulations pertaining to approval of genetic tests and bioinformatics tools
  • Moreover, the U.S. is observed to have highest number of installed sequencers, which in turn, has contributed to the large share of North America regional market
  • Asia Pacific is expected to emerge as the fastest growing regional market
  • Rise in genome-based projects coupled with constant GDP growth in Asian countries is expected to drive the Asia Pacific market
  • Illumina, Inc.; F. Hoffmann-La Roche Ltd; QIAGEN, Thermo Fisher Scientific, Inc.; and Oxford Nanopore Technologies are some of the major companies operating in this space

Grand View Research has segmented the global targeted DNA/RNA sequencing market on the basis of technology, workflow, application, type, end use, and region:

Technology Outlook (Revenue, USD Million, 2014 – 2025)

  • Next-generation Sequencing (NGS)
    • By Methods
      • Exome Sequencing
      • Enrichment Sequencing
      • Amplicon Sequencing
      • Others
    • By Applications
      • Cancer Gene Sequencing
      • Inherited Disease Screening
      • Drug Development
      • Forensic Genomics
      • 16S ribosomal RNA (rRNA) sequencing
    • Others

Workflow Outlook (Revenue, USD Million, 2014 – 2025)

  • Presequencing
  • Sequencing
  • Data Analysis

Application Outlook (Revenue, USD Million, 2014 – 2025)

  • Human Biomedical Research
  • Plant & Animal Sciences
  • Drug Discovery
  • Others

Type Outlook (Revenue, USD Million, 2014 – 2025)

  • DNA-based Targeted Sequencing
  • RNA-based Targeted Sequencing

End-use Outlook (Revenue, USD Million, 2014 – 2025)

  • Academic Research
  • Hospitals & Clinics
  • Pharma & Biotech Entities
  • Other Users

Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • China
    • Japan
  • Latin America
    • Brazil
  • Middle East & Africa
    • South Africa

Browse Press Release of this Report: http://www.grandviewresearch.com/press-release/global-targeted-dna-rna-sequencing-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Advertisements

Gastrointestinal Stents Market Is Expected To Raise At A CAGR of 4.7% Till 2025: Grand View Research, Inc.

The global Gastrointestinal Stents (GI Stents) Market is expected to reach USD 472.5 million by 2025, according to a new report by Grand View Research, Inc. Increasing burden of gastrointestinal diseases including biliary diseases, esophageal cancer, and colorectal cancer are anticipated to boost the usage of GI stents across the globe.

us-gastrointestinal-stents-market.png

Individuals above 60 years of age form the key target population for these products, as they are at a high risk of developing gastrointestinal and stomach-related diseases. Thus, aging demographics of most of the economies around the globe is a prime factor driving the growth of the sector. Moreover, reimbursement coverage provided by the Center for Medicare & Medicaid Services (CMS) and various private payers is spurring the adoption of GI stents.

Access Full Research Report on Gastrointestinal Stents Market:
http://www.grandviewresearch.com/industry-analysis/gastrointestinal-gi-stents-market

Further Key Findings from the Study Suggest:

  • The market study suggests that biliary stent dominated the overall sector in 2016. Incidences of biliary diseases such as bile duct cancer, gallstone disease and primary biliary cholangitis are on the rise globally, which would drive the growth of biliary stents sector positively.
  • Esophageal stent segment is expected to witness highest growth rate, owing to development of self-expanding plastic stents and self-expanding metal stents, which have proved to be safe and cost-effective for esophageal pathologies.
  • Approximately, 50 % to 75 % of patients who are primarily treated with endoscopic balloon dilation experience recurrence of the structure within 1 year. Such patients are treated with self-expanding metal stents, thereby driving the growth of the market segment.
  • North America occupied the largest revenue share in 2016, due to the high rate of diagnosing new cases of gastrointestinal diseases and constantly rising awareness regarding commercial availability of effective treatments.
  • In addition, increasing incidences of irritable bowel syndrome, colorectal cancer and pancreatic cancer are a few high impact-rendering drivers for the market
  • Asia Pacific is expected to witness a significant growth during the forecast period. The presence of countries such as Japan, China and India with constantly increasing patient population is a key factor anticipated to fuel the market growth in the region.
  • Some of the major companies operating in this market are Boston Scientific, Cook Medical, ELLA-CS, s.r.o., ConMed, Gore Medical, TaeWoong Medical, Hobbs Medical, Inc., C.R. Bard, Merit Endotek, Olympus America and others.

Read Our Blog: http://www.grandviewresearch.com/blogs/healthcare

Grand View Research has segmented the gastrointestinal stents market on the basis of product, application, and region:

Gastrointestinal Stents Product Outlook (Revenue, USD Million, 2014 – 2025)

  • Biliary Stent
  • Duodenal Stent
  • Colonic Stent
  • Pancreatic Stent
  • Esophageal Stent

Gastrointestinal Stents Application Outlook (Revenue, USD Million, 2014 – 2025)

  • Biliary Disease
  • Colorectal Cancer
  • Stomach Cancer
  • Others

Gastrointestinal Stents Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • China
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa

Browse Press Release of this Report: http://www.grandviewresearch.com/press-release/global-gastrointestinal-gi-stents-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

All Things you want to Know About Point-of-Care Infectious Disease Diagnostics Market

The global point-of-care infectious disease diagnostics/testing market is expected to reach USD 1.90 billion by 2025, according to a new report by Grand View Research, Inc. The emerging trend of patient-centric services coupled with escalating incidence rates of complicated infectious disorders is expected to upsurge the demand for portable and accurate detection devices, thus resulting in market growth. The potential in these devices to enable rapid detection of infectious diseases is attributive for the estimated market.

japan-poc-infectious-diseases-market.png

Moreover, revolutionizing patient care brought about by these devices is responsible for the rising demand for decentralized testing settings. Rise in the investments for R&D and development of new products is expected to spur progress in this market through to 2025.

For instance, development of a new ‘lab-on-a-disc’ technology developed by an EU project research team aids in the diagnosis of different infectious diseases including malaria. It enables faster diagnosis as a consequence of implementation of point-of-care treatment. This allows precise drugs administration thus influencing adoption rate.

Access Full Research Report on Point-of-Care Infectious Disease Diagnostics Market: http://www.grandviewresearch.com/industry-analysis/point-of-care-infectious-disease-diagnostics-testing-market

Further key findings from the report suggest:

  • HIV POC is estimated to account for the largest share owing to the rising incidence of this disease
  • Advances in the bio sensing technology for the early detection with sensitivity is expected to fuel revenue generation in the coming years
  • Moreover, companies are engaged in embracing a quality management approach for the introduction of novel tests for HIV diagnosis
  • TB and drug resistant TB is anticipated to witness lucrative demand in the coming years as a result of rise in the incidence rate of drug resistance TB
  • Demand for the development of inexpensive, rapid, simple, and accurate tests that are able to detect multiple biomarkers simultaneously is expected to boost progress
  • Implementation of fully or partially integrated nano/microscale technologies in developing DR-TB diagnostic devices is anticipated to fuel progress in the segment
  • Clinics accounted for the largest revenue share owing to the higher usage of rapid testing kits in clinics
  • North America dominates the space with adequate administration support, well-established healthcare framework, and extensive research & technology upgradation
  • Asia Pacific region is expected to showcase the fastest growth over the forecast period due to rising incidence and prevalence rates of infectious diseases with suitable government support
  • The major players in the sector include Siemens Healthineers, Trivitron Healthcare, F. Hoffmann-La Roche Ltd, Alere, Quest Diagnostics, Inc, BD & Company, Chembio Diagnostics Inc,Trinity Biotech, Cardinal Health,Bio-Rad Labs Inc.,bioMérieux SA, Thermo Fisher Scientific Inc, Sight Diagnostics Ltd.,Gene POC, Ortho-Clinical Diagnostics, and OJ-Bio Ltd.
  • Companies are entering into collaborations with academic institutions, private, and public entities to enhance their market share

Read Our Blog: http://www.grandviewresearch.com/blogs/healthcare

Grand View Research has segmented the point-of-care infectious disease diagnostics/testing market on the basis of disease, end-use, and region:

Disease Outlook (Revenue, USD Million; 2014-2025)

  • HIV POC
  • Clostridium difficile POC
  • HBV POC
  • Pneumonia or Streptococcus associated infections
  • Respiratory syncytial virus (RSV) POC
  • HPV POC
  • Influenza/Flu POC
  • HCV POC
  • MRSA POC
  • TB and drug-resistant TB POC
  • HSV (Herpes Simplex Virus) POC
  • Other infectious disease POC

End-Use Outlook (Revenue, USD Million; 2014-2025)

  • Hospitals
  • Clinics
  • Home
  • Assisted Living Healthcare Facilities
  • Laboratories
  • Others

Regional Outlook (Revenue, USD Million; 2014-2025)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
  • Middle East and Africa (MEA)
    • South Africa

View Press Release of this Report: http://www.grandviewresearch.com/press-release/global-point-of-care-infectious-disease-diagnostics-testing-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

E-Pharma Market Is Primarily Driven By Constant Increase In The Number Of Internet Users Till 2025

The global E-Pharma Market is expected to reach USD 109.2 billion by 2025, according to a new report by Grand View Research, Inc. The market is primarily driven by constant increase in the number of internet users, improved access to web-based & online services, and rapid increase in aging population who find it difficult to visit pharmacies. Convenience, affordability, and ease in availability of medicines are fueling market growth.

north-america-e-pharma-market.png

Increase in prevalence of chronic conditions and diseases across the globe is resulting in constant growth in demand for various drugs and healthcare products. High cost of treatment is indicating the need to reduce health care cost. Online pharmacies are gaining popularity owing to lucrative offers such as price discounts that result in cost savings. In addition, increase in adoption of e-prescriptions in hospitals and other healthcare facilities is further expected to boost growth.

High unmet needs of emerging economies is one of the key driving factors. Government initiatives, increase in investments, changing regulations, and increasing penetration of internet and broadband in urban as well as rural areas are contributing to the growth of the market. Many new players are entering the market as the healthcare sector is offering huge potential to the online health retailers due to the ever growing demand for healthcare products and services.

However, growth in illegal online pharmacies is restraining the growth. These illegitimate websites may offer counterfeit and unapproved drugs, which make people skeptical about purchasing medicines online.

Access Full Research Report on e-Pharma Market: http://www.grandviewresearch.com/industry-analysis/e-pharma-market

Further Key Findings From the Report Suggest:

  • North America held majority of the share in 2016 due to increase in online purchases, growing elderly population, and high adoption of IT in healthcare
  • The U.S. is the largest market in North America owing to the presence of various key players and a large tech-savvy population
  • Asia Pacific is expected to be the fastest growing segment due to the presence of emerging economies like China & India and improving infrastructure
  • Some of the key players are The Kroger Co., Walgreen Co.; Wal-Mart Stores, Inc.; CVS Health; Express Scripts Holding Company; Giant Eagle, Inc.; DocMorris (Zur Rose Group); Rowlands Pharmacy; and OptumRx, Inc.

Read Our Blog: http://www.grandviewresearch.com/blogs/healthcare

Grand View Research has segmented the e-Pharma Market on the basis of region:

e-Pharma Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa

View Press Release of this Report: http://www.grandviewresearch.com/press-release/global-e-pharma-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

 

Future Expansion and Growing Trends in Cancer Diagnostics Market Till 2025: Grand View Research, Inc.

The global Cancer Diagnostics Market is expected to reach USD 232.7 billion by 2025, according to a new report by Grand View Research, Inc. Continual introduction of innovative products coupled with increasing need for early diagnosis of the disease is the prime factor driving the market growth. In addition, rapid growth of the sector is attributed to the penetration of technologically advanced laboratory systems that have improved oncological screening in yielding accurate outcomes. Rising incidence of cancer is triggering the demand for these screening tests and imaging modalities that are used for monitoring disease progression.

china-cancer-diagnostics-market

Collaborative and independent initiatives led by governments and companies are striving to raise cognizance about the benefits of early diagnosis of the disease. In addition, cancer research organizations along with public and private entities are investing heavily on research projects to launch advanced diagnostic tools in the market, which are capable of diagnosing the disease way before the symptoms appear.

Furthermore, giant players are collaborating with governments and other agencies to enhance patient accessibility of their products. For instance, Illumina, Inc. launched a new venture named GRAIL with investors, Jeff Bezos and Bill Gates, with an investment of more than $100 million. GRAIL is mainly focused on blood-based oncological screening for timely diagnosis of the most common tumor types through simple laboratory tests.

Access Full Research Report on Cancer Diagnostics Market: http://www.grandviewresearch.com/industry-analysis/cancer-diagnostics-market

Further Key Findings from the Study Suggest:

  • Rapid adoption of technology and escalating need for early diagnosis is augmenting the growth of the imaging systems space. Thus, the segment is expected to grow at the fastest CAGR at over 8.0% during the forecast period.
  • The breast cancer segment, among other application segments, accounted for the largest share due to the high incidence rate of breast cancer triggering the need for its early diagnosis.
  • In 2016, North America dominated the global space with the largest revenue share of more than 41%. Focused research efforts in oncology for the development of early tumor detection tools coupled with grants from government healthcare agencies are contributing to a strong medical ecosystem to fight cancer in this region.
  • Asia Pacific is expected to emerge as the fastest growing region during the forecast period. The growing patient pool in India, China, and Japan; due to the support in diagnostic process at comparatively lower prices; and a favorable regulatory framework are some of the factors boosting the market growth in this region.
  • Major players competing in this market include GE Healthcare; Abbott; Hoffmann-La Roche Ltd and Siemens Healthcare GmbH. Other prominent players operating in the market include but are not limited to Becton Dickinson & Company; Illumina, Inc.; Koninklijke Philips N.V.; .and Hologic, Inc.

Read Our Blog: http://www.grandviewresearch.com/blogs/healthcare

Grand View Research has segmented the cancer diagnostics market by screening type, application, and region:

Cancer Diagnostics Screening Type Outlook (Revenue, USD Billion; 2014 – 2025)

  • Laboratory Tests
  • Genetic Tests
  • Imaging
  • Endoscopy
  • Biopsy
  • Others (barium enema)

Cancer Diagnostics Application Outlook (Revenue, USD Billion; 2014 – 2025)

  • Breast Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Lung Cancer
  • Prostate Cancer
  • Skin Cancer
  • Blood Cancer
  • Kidney Cancer
  • Liver Cancer
  • Pancreatic Cancer
  • Ovarian Cancer
  • Others

Cancer Diagnostics Regional Outlook (Revenue, USD Billion; 2014 – 2025)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Mexico
    • Brazil
  • MEA
    • South Africa

Browse Press Release of this Report: http://www.grandviewresearch.com/press-release/global-cancer-diagnostics-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Factor Affecting The Growth Of Infectious Disease Therapeutics Market In Future

The global Top 6 Infectious Disease Therapeutics Market is expected to reach USD 86.2 billion by 2025, according to a new report by Grand View Research, Inc. The market is primarily driven by increasing number of Human Immunodeficiency Virus (HIV), Human Papillomavirus (HPV), TB, and hepatitis cases globally.

infectious-disease-therapeutics-market.png

Government and private organizations are investing heavily in the healthcare sector to prevent, diagnose, and treat infectious diseases; rising investments for development of new drugs to treat infectious diseases, and increasing number of initiatives for creating awareness about these conditions are expected to boost the market during the forecast period. Furthermore, increasing number of patent expirations and entry of generic drugs in the market are expected to increase the demand for infectious disease therapeutics due to their low prices.

In addition, availability of reimbursement for diagnosis & treatment of these infections and free distribution of drugs by manufacturers in regions with high incidence of these diseases are factors further expected to propel the market growth. However, low penetration rate of anti-infective and availability of large number of counterfeit drugs are expected to restraint the market growth during the forecast period.

North American market held the largest share in 2016. Presence of large number of manufacturers, favorable reimbursement scenario, and increasing healthcare expenditure are major factors responsible for the largest share held by this region. However, Asia Pacific is likely to grow at the highest rate between 2017 and 2025. High prevalence of infectious diseases; improving economic conditions in Asian countries, rising government initiatives to increase the adoption of treatments for infectious diseases, and rising funding activities are factors that can be attributed for the highest growth rate of this region during the forecast period.

Access Full Research Report on Infectious Disease Therapeutics Market: http://www.grandviewresearch.com/industry-analysis/infectious-disease-therapeutics-market

Further Key Findings From the Report Suggest:

  • The HIV therapeutics segment held the largest revenue share in 2016 due to high number of HIV cases globally
  • North America dominated the global market owing to the strong reimbursement framework coupled with high adoption rate of treatments for infectious diseases
  • The HPV therapeutics segment is estimated to grow at the highest rate during the forecast period
  • Some of the key players areNovartis AG, Gilead, GlaxoSmithKline plc, Janssen Pharmaceutical, Inc., F. Hoffmann-La Roche Ltd., BioCryst Pharmaceuticals, Inc., and Boehringer Ingelheim GmbH

Read Our Blog: http://www.grandviewresearch.com/blogs/healthcare

Grand View Research has segmented the top 6 infectious disease therapeutics market on the basis of disease type and region:

Disease Type Outlook (Revenue, USD Million, 2014 – 2025)

  • HIV
    • Emtriva
    • Aptivus
    • Isentress
    • Lexiva/Telzir
    • Selzentry
    • Tivicay
    • Atripla
    • Complera
    • Genvoya
    • Odefsey
    • Stribild
    • Truvada
    • Triumeq
    • Descovy
    • Vitekta
    • Others
  • Influenza
    • Relenza
    • Tamiflu
    • Rapivab
    • Others
  • TB
    • Sirturo
    • Others
  • Malaria
    • Coartem
    • Others
  • HPV
  • Hepatitis

Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • China
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa

Browse Press Release of this Report: http://www.grandviewresearch.com/press-release/global-infectious-disease-therapeutics-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Healthcare EDI Market Is Anticipated To Witness A CAGR of 9.4% over the forecast period

The global Healthcare EDI Market is anticipated to reach USD 5.9 billion by 2025, according to a new report by Grand View Research, Inc. The market is expected to witness a CAGR of 9.4% over the forecast period, owing to increasing government support for healthcare IT coupled with surge in number of end-users and increasing adoption of EDI.

us-healthcare-edi-market.png

In 2010, the ObamaCare Act (the Affordable Care Act) was passed in the U.S., which mandated the use of enrolled/dis-enrolled transactions between the payers and providers in the U.S. Implementation of favorable policy such as Health Insurance Portability & Accountability Act (HIPAA) to provide data privacy and security provisions to protect medical information is anticipated to propel the market growth. Increasing government funding for the EDI-Special Project congressional grants is befitting hospitals and non-profit organization, thereby expected to foster the market growth.

A surge in number of end-users such as payers, providers, pharmaceutical & medical device industries, and others are anticipated to fuel the demand of the EDI services or solutions during the market period. The healthcare payers use EDI for the evaluation of insurance claims before their payment settlement, prevention & detection of fraudulent claims to provide rapid services through collaborating with providers in order to gain a competitive advantage.

Access Full Research Report on Healthcare EDI Market: http://www.grandviewresearch.com/industry-analysis/healthcare-electronic-data-interchange-edi-market

Further Key Findings From the Study Suggest:

  • The services segment held lucrative market share in 2016 and is expected to grow at a significant rate over the forecast period, owing to growing demand from healthcare and insurance providers for healthcare claims filing, its verification, and accounts receivables
  • The mobile EDI segment is expected to be the fastest growing segment over the forecast period due to technological developments in the healthcare industry and rising adoption of mobile solutions from healthcare providers
  • North America is expected to dominate the healthcare EDI market over the forecast period due to rising demand for innovative IT solutions to streamline workflows coupled with increasing regulatory requirements regarding patient safety
  • Some of the key players in healthcare EDI market are GE Healthcare; McKesson Corporation; Cognizant; Allscripts Healthcare Solutions Inc.; Siemens Healthineers; Optum, Inc.; Schreiner Group; The SSI Group, LLC; ZirMed Inc.; and Experian Information Solutions, Inc.

Read Our Blog: http://www.grandviewresearch.com/blogs/healthcare

Grand View Research has segmented the global healthcare EDI market on the basis of product, end-use, and region:

Healthcare EDI Component Outlook (Revenue, USD Million, 2014 – 2025)

  • Services
  • Solutions

Healthcare EDI Delivery Mode Outlook (Revenue, USD Million, 2014 – 2025)

  • Web and Cloud-based EDI
  • EDI Value Added Network (VAN)
  • Direct (Point-to-Point) EDI
  • Mobile EDI

Healthcare EDI End-use Outlook (Revenue, USD Million, 2014 – 2025)

  • Healthcare Payers
  • Healthcare Providers
  • Pharmaceutical & Medical Device Industries
  • Others

Healthcare EDI Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa (MEA)
    • South Africa

Browse Press Release of this Report: http://www.grandviewresearch.com/press-release/global-healthcare-electronic-data-interchange-edi-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com